Dr. Elie G. Dib
Claim this profileSaint Joseph Mercy Hospital
Expert in Cancer
Studies Breast Cancer
35 reported clinical trials
95 drugs studied
Area of expertise
1Cancer
Global LeaderStage IV
Stage III
EGFR negative
2Breast Cancer
HER2 negative
Stage I
Stage II
Affiliated Hospitals
Saint Joseph Mercy Hospital
Saint Joseph Mercy Brighton
Clinical Trials Elie G. Dib is currently running
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Relatlimab + Nivolumab
for Recurrent Glioblastoma
This phase II trial compares the safety, side effects and effectiveness of anti-lag-3 (relatlimab) and anti-PD-1 blockade (nivolumab) to standard of care lomustine for the treatment of patients with glioblastoma that has come back after a period of improvement (recurrent). Relatlimab and nivolumab are monoclonal antibodies that may interfere with the ability of tumor cells to grow and spread. Lomustine is a chemotherapy drug and in a class of medications called alkylating agents. It damages the cell's deoxyribonucleic acid (DNA) and may kill cancer cells. Relatlimab and nivolumab may be safe, tolerable, and/or effective compared to standard of care lomustine in treating patients with recurrent glioblastoma.
Recruiting1 award Phase 215 criteria
More about Elie G. Dib
Clinical Trial Related4 years of experience running clinical trials · Led 35 trials as a Principal Investigator · 21 Active Clinical TrialsTreatments Elie G. Dib has experience with
- Nivolumab
- Lenalidomide
- Atezolizumab
- Dexamethasone
- Durvalumab
- Pembrolizumab
Breakdown of trials Elie G. Dib has run
Cancer
Breast Cancer
Multiple Myeloma
Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Elie G. Dib specialize in?
Elie G. Dib focuses on Cancer and Breast Cancer. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage III.
Is Elie G. Dib currently recruiting for clinical trials?
Yes, Elie G. Dib is currently recruiting for 20 clinical trials in Ann Arbor Michigan. If you're interested in participating, you should apply.
Are there any treatments that Elie G. Dib has studied deeply?
Yes, Elie G. Dib has studied treatments such as Nivolumab, Lenalidomide, Atezolizumab.
What is the best way to schedule an appointment with Elie G. Dib?
Apply for one of the trials that Elie G. Dib is conducting.
What is the office address of Elie G. Dib?
The office of Elie G. Dib is located at: Saint Joseph Mercy Hospital, Ann Arbor, Michigan 48106 United States. This is the address for their practice at the Saint Joseph Mercy Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.